Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC).

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Production of IL-6 by T cells from the femoral head of patients with rapidly destructive coxopathy (RDC).

Clin Exp Immunol. 1996 Mar;103(3):506-13. Unique Identifier : AIDSLINE MED/96188966
Tamai M; Sagawa K; Kawabata R; Inoue A; Itoh K; Department of Immunology, Kurume University School of Medicine,; Fukuoka, Japan.

Abstract: RDC is a syndrome with unknown etiology that causes rapid destruction of a hip joint. We have investigated the production of osteoclast-activating cytokines (IL-6, IL-1alpha and tumour necrosis factor-alpha (TNF-alpha)), interferon-gamma (IFN-gamma) and IL-8 by T cells in the affected joint. The level of IL-6 produced by the T cell lines (TCL) established from the femoral head was significantly higher than that from patients' or healthy donors' peripheral blood mononuclear cells (PBMC). IL-6 production by the TCL from synovial membrane or from patients' PBMC was also significantly higher than that from healthy donors' PBMC. IL-1alpha production by the TCL from the femoral head was significantly higher than any of the other groups when all the TCL were used for the analysis. TNF-alpha production was highest in the TCL from patients' PBMC. The levels of IFN-gamma or IL-8 were not significantly different among these four groups. The plasma levels of all these cytokines except for IFN-gamma, that was rather lower, in RDC patients were not significantly different from those in osteoarthrosis or trauma patients, or healthy donors. These results suggest that T cells at the affected femoral head, and also synovial membrane to some extent, are involved in bone resorption through the production of IL-6 and probably IL-1alpha in patients with RDC.

Keywords: Aged Cell Line Cytokines/BLOOD CD4-CD8 Ratio Female Femur Head/CYTOLOGY *Hip Joint Human Interleukin-1/BLOOD Interleukin-6/*BIOSYNTHESIS/BLOOD Joint Diseases/*METABOLISM/*PATHOLOGY Middle Age Support, Non-U.S. Gov't T-Lymphocytes/*METABOLISM JOURNAL ARTICLE
960830
M9681211

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .